Log in to your account:
Bristol-Myers Squibb Co. (BMY) PT Raised to $55 at UBS
February 14, 2019 6:07 AM
UBS raised its price ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Analyst PT Change
Bristol-Myers Squibb (BMY) Reports Opdivo (nivolumab) Plus Yervoy (ipilimumab) Shows Response in Pre-Treated Patients with Metastatic Castration-Resistant Prostate Cancer
February 14, 2019 5:00 PM